Clinical trial
Long-term Interventional Follow-up Study up to 4 Years of Age of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial and Comparison With an Untreated Cohort of Children With Prader-Willi Syndrome
NCT05032326 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Interventional Follow-up Study up to 4 Years of Age of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial and Comparison With an Untreated Cohort of Children With Prader-Willi Syndrome
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 7, 2021
- Completion date
- April 1, 2025
- Enrollment
- 80 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.